Cargando…
Aptamers as quality control tool for production, storage and biosimilarity of the anti-CD20 biopharmaceutical rituximab
Detailed analysis of biopharmaceuticals is crucial for safety, efficacy and stability. Aptamers, which are folded, single-stranded oligonucleotides, can be used as surrogate antibodies to detect subtle conformational changes. We aimed to generate and assess DNA aptamers against the therapeutic anti-...
Autores principales: | Wildner, Sabrina, Huber, Sara, Regl, Christof, Huber, Christian G., Lohrig, Urs, Gadermaier, Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358617/ https://www.ncbi.nlm.nih.gov/pubmed/30710098 http://dx.doi.org/10.1038/s41598-018-37624-1 |
Ejemplares similares
-
Rituximab-specific DNA aptamers are able to selectively recognize heat-treated antibodies
por: Kohlberger, Michael, et al.
Publicado: (2020) -
A Simple Strategy to Eliminate Hexosylation Bias in the Relative Quantification of N‐Glycosylation in Biopharmaceuticals
por: Esser‐Skala, Wolfgang, et al.
Publicado: (2020) -
Simultaneous Monitoring of Monoclonal Antibody Variants by Strong Cation-Exchange Chromatography Hyphenated to Mass Spectrometry to Assess Quality Attributes of Rituximab-Based Biotherapeutics
por: Di Marco, Fiammetta, et al.
Publicado: (2021) -
Bioengineering of rFVIIa Biopharmaceutical and Structure Characterization for Biosimilarity Assessment
por: Montacir, Othman, et al.
Publicado: (2018) -
Biosimilars Have Arrived: Rituximab
por: Greenwald, Maria, et al.
Publicado: (2018)